These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections. Ehrhardt AF; Russo R Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441 [TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms. Orazi G; Jean-Pierre F; O'Toole GA J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077 [TBL] [Abstract][Full Text] [Related]
24. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076 [TBL] [Abstract][Full Text] [Related]
25. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)]. Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206 [TBL] [Abstract][Full Text] [Related]
26. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect]. Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251 [TBL] [Abstract][Full Text] [Related]
32. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639 [TBL] [Abstract][Full Text] [Related]
33. [Current microbiological aspects of community respiratory infection beyond COVID-19]. Cantón R Rev Esp Quimioter; 2021 Apr; 34(2):81-92. PubMed ID: 33749214 [TBL] [Abstract][Full Text] [Related]
34. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility. Yanagihara K; Watanabe A; Aoki N; Matsumoto T; Yoshida M; Sato J; Wakamura T; Sunakawa K; Kadota J; Kiyota H; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Takeuchi K; Takeda H; Ikeda H; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Morino E; Takasaki J; Mezaki K; Chonabayashi N; Tanaka C; Sugiura H; Goto H; Saraya T; Kurai D; Katono Y; Inose R; Niki Y; Takuma T; Kudo M; Ehara S; Sato Y; Tsukada H; Watabe N; Honma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Seki M; Hamaguchi S; Toyokawa M; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Nakamura T; Mikasa K; Kasahara K; Ui K; Fukuda S; Nakamura A; Morimura M; Yamashita M; Takesue Y; Wada Y; Sugimoto K; Kusano N; Nose M; Mihara E; Kuwabara M; Doi M; Watanabe Y; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Ota T; Fujita M; Honda J; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Kaku N; Fujita J; Higa F; Tateyama M J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567 [TBL] [Abstract][Full Text] [Related]
35. Antibiotic Susceptibility and Biofilm Formation of Bacterial Isolates Derived from Pediatric Patients with Cystic Fibrosis from Tehran, Iran. Kodori M; Nikmanesh B; Hakimi H; Ghalavand Z Arch Razi Inst; 2021 Jul; 76(2):397-406. PubMed ID: 34223738 [TBL] [Abstract][Full Text] [Related]
36. Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens. Zhu X; Ye T; Zhong H; Luo Y; Xu J; Zhang Q; Luo X; Wang Q; Zhang L; Song P; Zhang J Can J Infect Dis Med Microbiol; 2022; 2022():1181283. PubMed ID: 35368516 [TBL] [Abstract][Full Text] [Related]
37. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
38. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. Armbruster CE; Hong W; Pang B; Weimer KE; Juneau RA; Turner J; Swords WE mBio; 2010 Jul; 1(3):. PubMed ID: 20802829 [TBL] [Abstract][Full Text] [Related]
39. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system. Jean-Pierre F; Hampton TH; Schultz D; Hogan DA; Groleau MC; Déziel E; O'Toole GA Elife; 2023 Jan; 12():. PubMed ID: 36661299 [TBL] [Abstract][Full Text] [Related]
40. [Bacteria isolated from chronic upper and lower respiratory tract infections and the associated therapeutic strategies--in paranasal sinusitis]. Suzuki K Kansenshogaku Zasshi; 2006 Jan; 80(1):13-8. PubMed ID: 16519120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]